Protagonist Therapeutics <PTGX.O>: Barclays raises target price to $151 from $119
PTGX•Related News
Liberty Energy declares $0.09 quarterly dividend, payable Sept. 18
LBRT•
Gold edges higher on soft US inflation, Gulf conflict clouds rate outlook
GLD•
Nasdaq trade halt <NUVL.O> trading halted; for information requested by Nasdaq at 07:50 PM
NUVL•
Tenaya Therapeutics grants CFO Hyllengren options to buy 1.65 million shares at $0.84 each
TNYA•
Wife of Ryanair passenger sucked out of dislodged window recalls incident
RYAAY•